If you have been reading about Lyophilisation and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-07-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Alpha-MSH analogue with a lactam ring |
| Molecular formula | C50H69N15O9 | Commonly cited value for the neutral peptide |
| Molecular weight | 1024.18 g/mol | Calculated for the free molecule |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water, DMSO and ethanol | Dissolution in pure water is often slow |
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.
Independent verification is central to quality control because the compound is not produced under pharmaceutical manufacturing standards. Third-party laboratories can measure purity, identity, residual solvents, and microbial contamination, though the scope of testing varies between services. Reported analyses of vendor samples have shown batch-to-batch variation in peptide content and the presence of truncated or oxidized species. How much of this variation reflects synthesis conditions versus storage and shipping is not well characterized. No harmonized reference standard exists for the material as sold.
Handling guidance for melanotan II follows general practice for small synthetic peptides rather than a product-specific monograph. Lyophilized powder is typically kept at minus twenty degrees Celsius or colder, protected from light and moisture, because warmth and humidity accelerate degradation. Once reconstituted, solutions are usually refrigerated and used within a short window, as hydrolysis and microbial growth both become concerns. Repeated freeze-thaw cycles are generally avoided. These conventions come from laboratory peptide chemistry and not from formal stability studies on this specific compound.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Van Buren (1829), member of New York State Assembly Henry Ledyard (1830), mayor of Detroit; president of Newport Hospital Henry Nicoll (1830), U.S. congressman from New York Henry C. Murphy (1830), U.S. congressman from New York; former U.S. ambassador to the Netherlands John L. O'Sullivan (1831), US minister to Portugal; journalist who coined the term " Manifest Destiny"; publisher of The United States Magazine and Democratic Review James William Beekman (1834), member of the New York State Senate; vice-president of the New York Hospital Isaac C. Delaplaine (1834), U.S. congressman from New York John Richardson Thurman (1835), U.S. congressman from New York John Jay (1836), grandson of Chief Justice John Jay; United States minister to Austro-Hungary; president of the American Historical Association John Vanderbilt (1837), judge, member of the New York State Senate William Ward Duffield (1841), officer, member of the Michigan Senate, superintendent of the U.S. National Geodetic Survey Abram Stevens Hewitt (1842), former mayor of New York City and planner of the first line of the New York City Subway system; Chairman of the Democratic National Committee 1876–1877, son-in-law of philanthropist Peter Cooper Edward Cooper (1842), former mayor of New York City and son of industrialist Peter Cooper Nicholas B. La Bau (1844), member of the New York State Assembly and the New York State Senate John Winthrop Chanler (1847), U.S. congressman from New York Horace Carpentier (1848), first mayor of Oakland, California and president of the Overland Telegraph Company A.
MedPlus was founded in 2006 by Madhukar Gangadi. The company's first store was launched in Hyderabad. Initially operating under the Aushadhi brand name, it was rebranded as MedPlus after the opening of the first 48 stores. The company opened pharmacies in the western states of Gujarat and Rajasthan in 2007 but had to shut down and exit operations due to recurring losses. It relaunched stores in Ahmedabad, Gujarat in 2014. In 2008, it opened diagnostics centers in five cities under its subsidiary MedPlus Pathlabs. In 2015, it started its e-pharmacy division. In December 2021, MedPlus Health Services launched its initial public offering (IPO) and got listed on the Indian stock exchanges.
== Preparation == TCFH is commercially available. It may be prepared from tetramethylurea using a chlorinating agent such as oxalyl chloride, thionyl chloride or phosphorus oxychloride followed by a salt metathesis reaction.
=== Kava dermopathy === Long-term and heavy kava consumption is associated with a reversible skin condition known as "kava dermopathy", or kanikani (in the Fijian language), characterised by dry and scaly skin covering the palms of the hands, soles of the feet, and back. The first symptom to appear is usually dry, peeling skin; some Pacific Islanders deliberately consume large quantities of kava for several weeks in order to get the peeling effect, resulting in a layer of new skin. These effects appeared at consumption levels between 31 grams (1.1 oz) to 440 grams (0.97 lb) a week of kava powder. Despite numerous studies, the mechanism that causes kava dermopathy is poorly understood "but may relate to interference with cholesterol metabolism". The condition is easily treatable with abstinence or lowering of kava intake, as the skin appears to be returning to its normal state within a couple of weeks of reduced or no kava use. Kava dermopathy should not be confused with rare instances of allergic reactions to kava that are usually characterised by itchy rash or puffy face.
Sources: en.wikipedia.org
==== Copyright of AI-generated content ==== A separate question is whether AI-generated works can qualify for copyright protection. The United States Copyright Office has ruled that works created by artificial intelligence without any human input cannot be copyrighted, because they lack human authorship. Some legal professionals have suggested that Naruto v. Slater (2018), in which the U.S. 9th Circuit Court of Appeals held that non-humans cannot be copyright holders of artistic works, could be a potential precedent in copyright litigation over works created by generative AI. However, the office has also begun taking public input to determine if these rules need to be refined for generative AI. In January 2025, the United States Copyright Office (USCO) released extensive guidance regarding the use of AI tools in the creative process, and established that "...generative AI systems also offer tools that similarly allow users to exert control. [These] can enable the user to control the selection and placement of individual creative elements. Whether such modifications rise to the minimum standard of originality required under Feist will depend on a case-by-case determination. In those cases where they do, the output should be copyrightable" Subsequently, the USCO registered the first visual artwork to be composed of entirely AI-generated materials, titled "A Single Piece of American Cheese".
== Chairman of the Transitional Sovereignty Council (2021–present) == On 25 October 2021, al-Burhan led the October 2021 Sudanese coup d'état to overthrow the civilian government of Prime Minister Abdalla Hamdok. On 21 November 2021, all political prisoners were freed and Abdalla Hamdok was reinstated as prime minister as part of an agreement with the civilian political parties. Hamdok was also allowed to return leading the transitional government. After the coup, Burhan integrated Islamists into sources of power, in particular the SAF. Muslim Brotherhood members who had been active under the Bashir regime became among the principal supporters of al-Burhan and his rule. On 4 December 2021, al-Burhan told Reuters in an interview that the Sudanese military will "exit politics" following the elections scheduled for July 2023, stating, "When a government is elected, I don't think the army, the armed forces, or any of the security forces will participate in politics. This is what we agreed on and this is the natural situation." On 9 December 2021, al-Burhan warned of possible measures against foreign diplomatic missions for their alleged incitement against the Sudanese army. He also reiterated his commitment to the political agreement struck with Prime Minister Hamdok in November 2021. On 20 December 2021, al-Burhan voiced his support for Hamdok, adding that recent appointments had been made as the result of coordination between him and the prime minister and in line with the 21 November 2021 political agreement.
=== Antimicrobial Platelets === Platelet-mimicking particles engineered with antimicrobial properties offer a novel approach to combating infections by targeting pathogens at injury sites, enhancing immune responses, and delivering antimicrobial agents directly to affected areas. While platelets are often recognized for their hemostatic role, more recent research focuses on their ability to fight infections by releasing antimicrobial molecules and through interactions with immune cells. Building on these properties, synthetic antimicrobial platelets can be an attractive targeted therapy for preventing and treating infections, particularly in trauma, surgery, and immunocompromised patients. An approach to developing antimicrobial platelet-like particles (PLPs) involves the integration of nanosilver— a material known for its potent antimicrobial activity. Recent findings have reported that nanosilver composite PNIPAM microgels incorporated into PLPs (Ag-PLPs) effectively inhibited bacterial growth while maintaining key platelet functions such as deformability and clot retraction.4 This balance is needed in order for antimicrobial synthetic platelets to induce wound healing as well as hemostasis, while keeping infection risk at minimum. Ag-PLPs, in a wound experimental model, not only increased clot retraction but also performance of healing, suggesting its regard as a "two-in-one therapy" for high-risk infection trauma patients.
==== Labour and Employment, 2026-2028 ==== Lad is Inducted as Labour and Employment Minister of DK Shivakumar's Cabinet after reconstitution of Karnataka in 2026. He is also entrusted with responsibility of overseeing Dharwad District as In charge Minister.
=== Judaism === Israeli prime minister Benjamin Netanyahu referenced the Torah and compared Iran to the ancient biblical enemy of the Amalekites, stating "We read in this week's Torah portion, 'Remember what Amalek did to you.' We remember—and we act." The Council on American–Islamic Relations condemned Netanyahu for "once again using the biblical story of Amalek—which claims that God commanded the Israelites to murder every man, woman, child and animal in a pagan nation that attacked them—to justify Israel's mass murder of civilians in Iran, just as it did in Gaza."
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.
No national medicines agency has approved melanotan-2 for clinical use. Afamelanotide, a related but distinct peptide, holds a marketing authorisation in the European Union for a rare photosensitivity disorder. Melanotan-2 itself is handled as a laboratory chemical.
Its broad activity across melanocortin receptors makes it a tool for probing pigmentation, appetite and vascular signalling. Early trials recorded skin darkening and other effects that were not the original focus of the work. Those observations generated hypotheses that later studies have examined.
Mass spectrometry combined with liquid chromatography provides both molecular weight confirmation and a measure of related impurities. Tandem mass spectrometry adds sequence information. A purity percentage reported without a mass measurement does not confirm what the material is.